| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 1867 | 2020 |
| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1399 | 2019 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients OA Cornely, M Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, ... Clinical Microbiology and Infection 18, 19-37, 2012 | 1299 | 2012 |
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1271 | 2018 |
| Trends in the postmortem epidemiology of invasive fungal infections at a university hospital AH Groll, PM Shah, C Mentzel, M Schneider, G Just-Nuebling, K Huebner Journal of infection 33 (1), 23-32, 1996 | 1045 | 1996 |
| Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 A Skiada, L Pagano, A Groll, S Zimmerli, B Dupont, K Lagrou, C Lass-Florl, ... Clinical Microbiology and Infection 17 (12), 1859-1867, 2011 | 799 | 2011 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ... Clinical Microbiology and Infection 20, 5-26, 2014 | 728 | 2014 |
| Infections due to emerging and uncommon medically important fungal pathogens TJ Walsh, A Groll, J Hiemenz, R Fleming, E Roilides, E Anaissie Clinical Microbiology and Infection 10, 48-66, 2004 | 726 | 2004 |
| ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients F Tissot, S Agrawal, L Pagano, G Petrikkos, AH Groll, A Skiada, ... haematologica 102 (3), 433, 2017 | 660 | 2017 |
| Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children TJ Walsh, I Lutsar, T Driscoll, B Dupont, M Roden, P Ghahramani, ... The Pediatric infectious disease journal 21 (3), 240-248, 2002 | 534 | 2002 |
| ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ... Clinical Microbiology and Infection 20, 27-46, 2014 | 469 | 2014 |
| Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update T Lehrnbecher, P Robinson, B Fisher, S Alexander, RA Ammann, ... Journal of Clinical Oncology 35 (18), 2082-2094, 2017 | 468 | 2017 |
| Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal … AH Groll, SC Piscitelli, TJ Walsh Advances in pharmacology 44, 343-500, 1998 | 464 | 1998 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures M Cuenca‐Estrella, PE Verweij, MC Arendrup, S Arikan‐Akdagli, J Bille, ... Clinical Microbiology and Infection 18, 9-18, 2012 | 461 | 2012 |
| Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3) A Skiada, F Lanternier, AH Groll, L Pagano, S Zimmerli, R Herbrecht, ... haematologica 98 (4), 492, 2013 | 428 | 2013 |
| Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in Experimental Candida albicans Infection of the Central Nervous System AH Groll, N Giri, V Petraitis, R Petraitiene, M Candelario, JS Bacher, ... The Journal of infectious diseases 182 (1), 274-282, 2000 | 421 | 2000 |
| Uncommon opportunistic fungi: new nosocomial threats AH Groll, TJ Walsh Clinical Microbiology and Infection 7, 8-24, 2001 | 420 | 2001 |
| Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation T Lehrnbecher, R Phillips, S Alexander, F Alvaro, F Carlesse, B Fisher, ... J Clin Oncol 30 (35), 4427-4438, 2012 | 417* | 2012 |
| Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty‐first century TJ Walsh, AH Groll Transplant infectious disease 1 (4), 247-261, 1999 | 417 | 1999 |
| Newer systemic antifungal agents: pharmacokinetics, safety and efficacy HW Boucher, AH Groll, CC Chiou, TJ Walsh Drugs 64, 1997-2020, 2004 | 412 | 2004 |
Thomas LehrnbecherVerified email at kgu.de
